Kendra E. McCarty, PA-C

Kendra McCarty practices at Advanced Dermatology and Skin Care PA in Katy, Texas.

Kendra McCarty's NPI, 1518281815, was assigned on March 16, 2010. Kendra McCarty holds Texas license PA06634.

Kendra McCarty's primary practice is Advanced Dermatology and Skin Care PA, at 430 S Mason Rd, Katy, TX 77450 in Harris County. The practice phone is (281) 392-3803.

Kendra McCarty's primary practice is Advanced Dermatology and Skin Care PA in Katy, Texas. The medical group on file is Advanced Dermatology. Dmand AI also links Kendra McCarty to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kendra McCarty practices, 3 sites in all. Vendor and product names are available with a free account.

Physician assistant is Kendra McCarty's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Kendra McCarty is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Kendra McCarty is licensed in Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, itchy rashes, minor injury to a limb and psoriasis among the conditions Kendra McCarty treats.

CMS data shows 1,359 Medicare services from Kendra McCarty across 10 procedure codes in 2024, for 200 Medicare patients. Medicare paid $49,844 for them. Every service was in an office.

CMS counts 200 Medicare patients who saw Kendra McCarty in 2024. The largest group is 65 to 74, with 131 patients. 75% of them have high cholesterol, and 74% have high blood pressure. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Kendra McCarty's median patient age at 58, with 56% women.

In 2024, Kendra McCarty wrote 392 Medicare Part D claims for 172 patients. 93% of them were for generic drugs. CMS names the drug for 275 of them, across 9 drugs with 11 or more claims each, at $5,119 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Kendra McCarty for performance year 2024, reported as part of a group. Kendra McCarty accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 202 general payments to Kendra McCarty from 23 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 93% of the total. Sanofi and Genzyme US Companies paid the most, $760.